The Latest Breaking News from FDA

The biotech industry flourished during the height of the COVID-19 pandemic and reported record revenues and earnings last year. Despite the market slowdown, the sector is poised for another bull run, given the continued global fight against COVID-19 and the increasing demand with an aging population. Popular biotech stocks Pfizer…

Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.

If approved, the drug could increase access to effective birth control.

The agency is considering the application by HRA Pharma to make Opill available without a prescription

Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.

These devices measure blood oxygen levels and can help identify when patients are dangerously ill. But research shows they can deliver misleading results for people with darker skin.

Disposable gowns designed to deflect the splatter of bodily fluids, used in thousands of U.S. hospitals, have underperformed in recent and ongoing laboratory tests and may fall short of safety standards, leaving health care workers with a greater risk of infection than advertised.

"This historic application marks a groundbreaking moment in contraceptive access and reproductive equity."

A drug company is seeking U.S. approval for the first birth control pill that women could buy without a prescription

Q: I have heard that there’s an approved COVID-19 vaccine for children under 5. What do I need to know about it?

Factory in Sturgis, Michigan shut down in May after storms that produced torrential flooding